Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients

Nutrition Research

Volumn 26, Issue 9, 2006, Pages 460-466

  Lin, Ping Ting ^a   Lee, Bor Jen ^b   Chang, Han Hsin ^b   Cheng, Chien Hsiang ^a   Tsai, An Jung ^c   Huang, Yi Chia ^a  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Coronary artery disease; Folic acid supplementation; Homocysteine; Humans; Low dose; Methylenetetrahydrofolate reductase

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); FOLIC ACID; HOMOCYSTEINE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONCENTRATION (PARAMETERS); CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIET SUPPLEMENTATION; DRUG EFFECT; FEMALE; GENOTYPE; HUMAN; HYPERHOMOCYSTEINEMIA; LOW DRUG DOSE; MALE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; STATISTICAL SIGNIFICANCE;

EID: 33749258910     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2006.08.001     Document Type: Article

References (35)

1. Stampfer M.J., Malinow M.R., Willett W.C., Newcomer L.M., Upson B., Ullmann D., et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA 268 (1992) 877-881
2. Boushey C.J., Beresford S.A.A., Omenn G.S., and Motulsky A.G. A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intake. JAMA 274 (1995) 1049-1057
3. Refsum H., and Ueland P.M. Recent data are not in conflict with homocysteine as a cardiovascular risk factor. Curr Opin Lipidol 9 (1998) 533-539
4. Ubbink J.B., Vermaak W.J.H., van der Merwe A., Becker P.J., Delport R., and Potgieter H.C. Vitamin requirements for the treatment of hyperhomocysteinemia in humans. J Nutr 124 (1994) 1927-1933
5. 12, and folate. Am J Epidemiol 143 (1996) 845-859
6. Lee B.J., Lin P.T., Liaw Y.P., Chang S.J., Cheng C.H., and Huang Y.C. Homocysteine and risk of coronary artery disease: Folate is the important determinant of plasma homocysteine concentration. Nutrition 19 (2003) 577-583
7. Kang S.S., Zhou J., Wong P.W., Kowalisyn J., and Strokosch G. Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. Am J Hum Genet 43 (1988) 414-421
8. Engbersen A.M., Franken D.G., Boers G.H., Stevens E.M., Trijbels F.J., and Blom H.J. Thermolabile 5,10-methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia. Am J Hum Genet 56 (1995) 142-150
9. Frosst P., Blom H.J., Milos R., Goyette P., Sheppard C.A., Matthews R.G., et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10 (1995) 111-113
10. den Heijer M., Rosendaal F.R., Blom H.J., Gerrits W.B., and Bos G.M. Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 80 (1998) 874-877
11. 6 in lowering fasting plasma homocysteine concentration in patients with coronary artery disease. Eur J Clin Nutr 58 (2004) 481-487
12. Liu C.S., Chiang H.C., and Chen H.W. Methylenetetrahydrofolate reductase polymorphism determines the plasma homocysteine-lowering effect of large-dose folic acid supplementation in patients with cardiovascular disease. Nutrition 20 (2004) 974-978
13. 6 supplementation and plasma homocysteine concentrations in healthy young women. Int J Vitam Nutr Res 68 (1998) 98-103
14. Brouwer I.A., van Dusseldorp M., Thomas C.M., Duran M., Hautvast J.G., Eskes T.K., et al. Low-dose folic acid supplementation decreases plasma homocysteine concentrations: a randomized trial. Am J Clin Nutr 69 (1999) 99-104
15. Fohr I.P., Prinz-Langenohl R., Bronstrup A., Bohlmann A.M., Nau H., Berthold H.K., et al. 5,10-Methylenetetrahydrofolate reductase genotype determines the plasma homocysteine-lowering effect of supplementation with 5-methyltetrahydrofolate or folic acid in healthy young women. Am J Clin Nutr 75 (2002) 275-282
16. Jacques P.F., Bostom A.G., Williams R.R., Ellison R.C., Eckfeldt J.H., Rosenberg I.H., et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation 93 (1996) 7-9
17. Malinow M.R., Nieto F.J., Kruger W.D., Duell P.B., Hess D.L., Gluckman R.A., et al. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arterioscler Thromb Vasc Biol 17 (1997) 1157-1162
18. Malinow M.R., Bostom A.G., and Krauss R.M. Homocyst(e)ine, diet, and cardiovascular diseases: a statement for healthcare professionals from the Nutrition Committee, American Heart Association. Circulation 99 (1999) 178-182
19. Araki A., and Sako Y. Determination of free and total homocysteine in human plasma by high-performance liquid chromatography with fluorescence detection. J Chromatogr 422 (1987) 43-52
20. Bates C.J., Pentieva K.D., Matthews N., and Macdonald A. A simple, sensitive and reproducible assay for pyridoxal 5′-phosphate and 4-pyridoxic acid in human plasma. Chin Chim Acta 280 (1999) 101-111
21. Anderson J.L., King G.J., Thomson J., Todd M., Bair T.L., Muhlestein J.B., et al. A mutation in the methylenetetrahydrofolate reductase gene is not associated with increase risk for coronary artery disease or myocardial infarction. J Am Coll Cardiol 30 (1997) 1206-1211
22. Markus H.S., Ali N., Swaminathan R., Sankaralingam A., Molloy J., and Powell J. A common polymorphism in the methylenetetrahydrofolate reductase gene, homocysteine, and ischemic cerebrovascular disease. Stroke 28 (1997) 1739-1743
23. 6 on lipid and homocysteine concentrations in patients with coronary artery disease. Nutrition 18 (2002) 428-429
24. Brody T. Folic acid. In: Machlin L.J. (Ed). Handbook of vitamins. 2nd ed (1991), Dekker Press, New York 475
25. Groff J.L., and Gropper S.S. Folic acid. In: Hunt S.M. (Ed). Advanced nutrition and human metabolism. 2nd ed (1995), West Publishing Press, New York 269
26. Selhub J., Jacques P.F., Wilson P.W., Rush D., and Rosenberg I.H. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270 (1993) 2693-2698
27. Ashfield-Watt P.A.L., Pullin C.H., Whiting J.M., Clark Z.E., Moat S.J., Newcombe R.G., et al. Methylenetetrahydrofolate reductase 677C→T genotype modulates homocysteine responses to a folate-rich diet or a low-dose folic acid supplement: a randomized controlled trial. Am J Clin Nutr 76 (2002) 180-186
28. van Oort F.V.A., Melse-Boonstra A., Brouwer I.A., Clarke R., West C.E., Katan M.B., et al. Folic acid and reduction of plasma homocysteine concentrations in older adults: a dose-response study. Am J Clin Nutr 77 (2003) 1318-1323
29. 12. Am J Cardiol 83 (1999) 821-825
30. Rydlewicz A., Simpson J.A., Taylor R.J., Bond C.M., and Golden M.H.N. The effect of folic acid supplementation on plasma homocysteine in an elderly population. Q J Med 95 (2002) 27-35
31. Chen K.J., Pan W.H., Yang F.L., Wei I.L., Shaw N.S., and Lin B.F. Association between dietary folate-rich food intake and folate status of elderly Taiwanese. Asia Pac J Clin Nutr 14 (2005) 244-249
32. Chen K.J., Pan W.H., Yang F.L., Wei I.L., Shaw N.S., and Lin B.F. Association of B vitamins status and concentrations of homocysteine in Taiwanese elderly people. Asia Pac J Clin Nutr 14 (2005) 250-255
33. Mager A., Lalezari S., Shohat T., Birnbaum Y., Adler Y., Nagal N., et al. Methylenetetrahydrofolate reductase genotypes, and early-onset coronary artery disease. Circulation 100 (1999) 2406-2410
34. 12 and homocysteine. Nutr Res 22 (2002) 965-976
35. de Bree A., Verschuren W.M., Bjørke-Monsen A.L., van der Put N.M.J., Heil S.G., Trijbels F.J.M., et al. Effect of the methylenetetrahydrofolate reductase 677C→T mutation on the relations among folate intake and plasma folate and homocysteine concentrations in a general population sample. Am J Clin Nutr 77 (2003) 687-693